Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1
- PMID: 15607795
- DOI: 10.1016/j.molimm.2004.07.023
Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1
Abstract
Substantial attention has been paid to the role of the toll-like receptor (TLR) ligands of late and their role in regulating the innate immune response. They serve as exogenous danger signals important in informing and driving the distal adaptive immune response to pathogens. Less clear has been the role of the nominal endogenous danger signals released and recognized in stressed cells following genotoxic or metabolic stress as occurs in progressively growing tumors. HMGB1 (high-mobility group B1) is a nuclear protein well characterized for its ability to modify DNA access to transcriptional proteins that is released from necrotic cells as well as secreted through the endosomal route from hematopoietic cells, serving as a late mediator of sepsis. It interacts with high-affinity RAGE (receptor for advanced glycation end products) and TLR2 receptors. Here we show that HMGB1 enhances interferon gamma release from macrophage (but not dendritic cell)-stimulated NK cells. This is effective only when coupled with other pro-inflammatory cytokines particularly with IL-2 in combination with IL-1 or IL-12. We have used this information to suggest that HMGB1, which also promotes epithelial migration and proliferation, drives repair in the absence or inhibition of other factors but enhances inflammation in their presence. The implications for tumorigenesis and tumor progression are quite important as they may be for other states of chronic inflammation.
Similar articles
-
Pathogen-induced private conversations between natural killer and dendritic cells.Trends Microbiol. 2005 Mar;13(3):128-36. doi: 10.1016/j.tim.2005.01.006. Trends Microbiol. 2005. PMID: 15737731 Review.
-
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Angiogenesis. 2008. PMID: 18264787 Review.
-
Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.AIDS. 2009 Mar 13;23(5):567-77. doi: 10.1097/QAD.0b013e328325a47e. AIDS. 2009. PMID: 19194273
-
Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.Eur J Immunol. 2004 Jun;34(6):1503-12. doi: 10.1002/eji.200424916. Eur J Immunol. 2004. PMID: 15162419 Review.
-
Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.Int Immunol. 2007 Mar;19(3):311-20. doi: 10.1093/intimm/dxl148. Epub 2007 Feb 7. Int Immunol. 2007. PMID: 17289654
Cited by
-
Exercise training and immune crosstalk in breast cancer microenvironment: exploring the paradigms of exercise-induced immune modulation and exercise-induced myokines.Am J Transl Res. 2014 Oct 11;6(5):422-38. eCollection 2014. Am J Transl Res. 2014. PMID: 25360210 Free PMC article. Review.
-
Immunomodulation of NK Cells by Ionizing Radiation.Front Oncol. 2020 Jun 16;10:874. doi: 10.3389/fonc.2020.00874. eCollection 2020. Front Oncol. 2020. PMID: 32612950 Free PMC article. Review.
-
HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.J Neurosci. 2006 Jun 14;26(24):6413-21. doi: 10.1523/JNEUROSCI.3815-05.2006. J Neurosci. 2006. PMID: 16775128 Free PMC article.
-
Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model.PLoS Comput Biol. 2022 Mar 16;18(3):e1009953. doi: 10.1371/journal.pcbi.1009953. eCollection 2022 Mar. PLoS Comput Biol. 2022. PMID: 35294447 Free PMC article.
-
High mobility group box 1 and adenosine are both released by endothelial cells during hypothermic preservation.Clin Exp Immunol. 2008 May;152(2):311-9. doi: 10.1111/j.1365-2249.2008.03643.x. Epub 2008 Mar 12. Clin Exp Immunol. 2008. PMID: 18341609 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases